ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.
A new analytical tool points to genes that act together to increase disease risk.
Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.
Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.
Accessibility Tools